254 related articles for article (PubMed ID: 21483670)
21. Identification of pro-inflammatory cytokines associated with muscle invasive bladder cancer; the roles of IL-5, IL-20, and IL-28A.
Lee SJ; Lee EJ; Kim SK; Jeong P; Cho YH; Yun SJ; Kim S; Kim GY; Choi YH; Cha EJ; Kim WJ; Moon SK
PLoS One; 2012; 7(9):e40267. PubMed ID: 22962576
[TBL] [Abstract][Full Text] [Related]
22. Integrated bioinformatics analysis for differentially expressed genes and signaling pathways identification in gastric cancer.
Yang C; Gong A
Int J Med Sci; 2021; 18(3):792-800. PubMed ID: 33437215
[No Abstract] [Full Text] [Related]
23. Comprehensive circular RNA profiling reveals the regulatory role of the hsa_circ_0137606/miR‑1231 pathway in bladder cancer progression.
Li W; Li Y; Sun Z; Zhou J; Cao Y; Ma W; Xie K; Yan X
Int J Mol Med; 2019 Nov; 44(5):1719-1728. PubMed ID: 31545480
[TBL] [Abstract][Full Text] [Related]
24. Phospho-Akt pathway activation and inhibition depends on N-cadherin or phospho-EGFR expression in invasive human bladder cancer cell lines.
Wallerand H; Cai Y; Wainberg ZA; Garraway I; Lascombe I; Nicolle G; Thiery JP; Bittard H; Radvanyi F; Reiter RR
Urol Oncol; 2010; 28(2):180-8. PubMed ID: 19070520
[TBL] [Abstract][Full Text] [Related]
25. Prediction of recurrence in low and intermediate risk non-muscle invasive bladder cancer by real-time quantitative PCR analysis: cDNA microarray results.
Mares J; Szakacsova M; Soukup V; Duskova J; Horinek A; Babjuk M
Neoplasma; 2013; 60(3):295-301. PubMed ID: 23452234
[TBL] [Abstract][Full Text] [Related]
26. Expression of genes related to apoptosis, cell cycle and signaling pathways are independent of TP53 status in urinary bladder cancer cells.
da Silva GN; Evangelista AF; Magalhães DA; Macedo C; Búfalo MC; Sakamoto-Hojo ET; Passos GA; Salvadori DM
Mol Biol Rep; 2011 Aug; 38(6):4159-70. PubMed ID: 21116856
[TBL] [Abstract][Full Text] [Related]
27. Differentially expressed genes in metastatic advanced Egyptian bladder cancer.
Zekri AR; Hassan ZK; Bahnassy AA; Khaled HM; El-Rouby MN; Haggag RM; Abu-Taleb FM
Asian Pac J Cancer Prev; 2015; 16(8):3543-9. PubMed ID: 25921176
[TBL] [Abstract][Full Text] [Related]
28. Implication of RAF and RKIP genes in urinary bladder cancer.
Zaravinos A; Chatziioannou M; Lambrou GI; Boulalas I; Delakas D; Spandidos DA
Pathol Oncol Res; 2011 Jun; 17(2):181-90. PubMed ID: 20853079
[TBL] [Abstract][Full Text] [Related]
29. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
30. Screening of differentially expressed genes related to bladder cancer and functional analysis with DNA microarray.
Huang YD; Shan W; Zeng L; Wu Y
Asian Pac J Cancer Prev; 2013; 14(8):4553-7. PubMed ID: 24083701
[TBL] [Abstract][Full Text] [Related]
31. Analysis of Gene Expression in Bladder Cancer: Possible Involvement of Mitosis and Complement and Coagulation Cascades Signaling Pathway.
Liu Y; Xiong S; Liu S; Chen J; Yang H; Liu G; Li G
J Comput Biol; 2020 Jun; 27(6):987-998. PubMed ID: 31545079
[TBL] [Abstract][Full Text] [Related]
32. Transcriptomic analysis of high-throughput sequencing about circRNA, lncRNA and mRNA in bladder cancer.
Li M; Liu Y; Zhang X; Liu J; Wang P
Gene; 2018 Nov; 677():189-197. PubMed ID: 30025927
[TBL] [Abstract][Full Text] [Related]
33. Bladder cancer outcome and subtype classification by gene expression.
Blaveri E; Simko JP; Korkola JE; Brewer JL; Baehner F; Mehta K; Devries S; Koppie T; Pejavar S; Carroll P; Waldman FM
Clin Cancer Res; 2005 Jun; 11(11):4044-55. PubMed ID: 15930339
[TBL] [Abstract][Full Text] [Related]
34. Molecular network-based identification of competing endogenous RNAs in bladder cancer.
Jiang WD; Yuan PC
PLoS One; 2019; 14(8):e0220118. PubMed ID: 31369587
[TBL] [Abstract][Full Text] [Related]
35. A five-gene expression signature to predict progression in T1G3 bladder cancer.
van der Heijden AG; Mengual L; Lozano JJ; Ingelmo-Torres M; Ribal MJ; Fernández PL; Oosterwijk E; Schalken JA; Alcaraz A; Witjes JA
Eur J Cancer; 2016 Sep; 64():127-36. PubMed ID: 27414486
[TBL] [Abstract][Full Text] [Related]
36. Microarray gene expression profiling and analysis of bladder cancer supports the sub-classification of T1 tumours into T1a and T1b stages.
Descotes F; Dessen P; Bringuier PP; Decaussin M; Martin PM; Adams M; Villers A; Lechevallier E; Rebillard X; Rodriguez-Lafrasse C; Devonec M; Paparel P; Perrin P; Lazar V; Ruffion A
BJU Int; 2014 Feb; 113(2):333-42. PubMed ID: 24053469
[TBL] [Abstract][Full Text] [Related]
37. Galectin-3 expression is associated with bladder cancer progression and clinical outcome.
Canesin G; Gonzalez-Peramato P; Palou J; Urrutia M; Cordón-Cardo C; Sánchez-Carbayo M
Tumour Biol; 2010 Aug; 31(4):277-85. PubMed ID: 20401558
[TBL] [Abstract][Full Text] [Related]
38. Gene expression is highly correlated on the chromosome level in urinary bladder cancer.
Lambrou GI; Adamaki M; Delakas D; Spandidos DA; Vlahopoulos S; Zaravinos A
Cell Cycle; 2013 May; 12(10):1544-59. PubMed ID: 23624844
[TBL] [Abstract][Full Text] [Related]
39. Overexpression of caldesmon is associated with tumor progression in patients with primary non-muscle-invasive bladder cancer.
Lee MS; Lee J; Kim JH; Kim WT; Kim WJ; Ahn H; Park J
Oncotarget; 2015 Nov; 6(37):40370-84. PubMed ID: 26430961
[TBL] [Abstract][Full Text] [Related]
40. A molecular signature in superficial bladder carcinoma predicts clinical outcome.
Dyrskjøt L; Zieger K; Kruhøffer M; Thykjaer T; Jensen JL; Primdahl H; Aziz N; Marcussen N; Møller K; Orntoft TF
Clin Cancer Res; 2005 Jun; 11(11):4029-36. PubMed ID: 15930337
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
